Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-27
1996-09-17
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142278, 514252, 514475, 544584, 544146, 544147, 544374, 549548, 549549, A61K 31535, C07D41312
Patent
active
055568530
ABSTRACT:
A compound of the general formula: ##STR1## wherein R.sup.1 represents a carboxyl group which may optionally be esterified or amidated; R.sup.2 represents a cyclic group which may optionally be substituted or a polar group; n is an integer of 0 to 6; R.sup.3 represents hydrogen or a hydrocarbon residue which may optionally be substituted; R.sup.4 represents (1) a hydrocarbon residue which is substituted by an optionally protected amino group or (2) an alkenyl group; or R.sup.3 and R.sup.4 may be combined with the adjacent nitrogen atom to form a heterocyclic group containing at least two hetero atoms, or a salt thereof.
The compound or a salt thereof of the present invention inhibits thiol proteases such as cathepsin L and B and serves well as a prophylactic/therapeutic agent for bone diseases such as osteoporosis.
REFERENCES:
patent: 4333879 (1982-06-01), Tamai et al.
patent: 4418075 (1983-11-01), Tamai et al.
patent: 4507297 (1985-03-01), Masaki et al.
patent: 4596803 (1986-06-01), Masaki et al.
Fukushima et al., "Metabolic Fate of Loxistatin in Rat" Xenobiotica, 1990, vol. 20, No. 10, 1043-1051.
Fujisawa Yukio
Masayuki Takizawa
Mikio Shirasaki
Tsubotani Shigetoshi
Ramsuer Robert W.
Takeda Chemical Industries Ltd.
LandOfFree
Epoxysuccinic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epoxysuccinic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epoxysuccinic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413242